- Home
- NSAI vs PAVM Comparison
NSAI vs PAVM Comparison
Compare NSAI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSAI | PAVM |
|---|---|---|
| Founded | 2026 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.9M | 41.1M |
| IPO Year | 2026 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NSAI | PAVM |
|---|---|---|
| Price | $10.00 | $1.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | ★ 40.7K | 10.3K |
| Earning Date | N/A | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,000,000.00 |
| Revenue This Year | N/A | $132.39 |
| Revenue Next Year | N/A | $263.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $9.82 | $0.21 |
| 52 Week High | $10.00 | $43.99 |
Technical Indicators
Market Signals| Indicator | NSAI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 70.27 | 24.27 |
| Support Level | $9.82 | N/A |
| Resistance Level | N/A | $6.56 |
| Average True Range (ATR) | 0.02 | 0.19 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 100.00 | 31.07 |
Price Performance
Historical ComparisonAbout NSAI NorthStrive Acquisition Corp I. Class A Ordinary Shares
NorthStrive Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.